TY - JOUR
T1 - Elimination of purkinje fibers by electroporation reduces ventricular fibrillation vulnerability
AU - Livia, Christopher
AU - Sugrue, Alan
AU - Witt, Tyra
AU - Polkinghorne, Murray D.
AU - Maor, Elad
AU - Kapa, Suraj
AU - Lehmann, Helge I.
AU - DeSimone, Christopher V.
AU - Behfar, Atta
AU - Asirvatham, Samuel J.
AU - McLeod, Christopher J.
N1 - Publisher Copyright:
© 2018 The Authors.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Background-The Purkinje network appears to play a pivotal role in the triggering as well as maintenance of ventricular fibrillation. Irreversible electroporation (IRE) using direct current has shown promise as a nonthermal ablation modality in the heart, but its ability to target and ablate the Purkinje tissue is undefined. Our aim was to investigate the potential for selective ablation of Purkinje/fascicular fibers using IRE. Methods and Results-In an ex vivo Langendorff model of canine heart (n=8), direct current was delivered in a unipolar manner at various dosages from 750 to 2500 V, in 10 pulses with a 90-µs duration at a frequency of 1 Hz. The window of ventricular fibrillation vulnerability was assessed before and after delivery of electroporation energy using a shock on T-wave method. IRE consistently eradicated all Purkinje potentials at voltages between 750 and 2500 V (minimum field strength of 250-833 V/cm). The ventricular electrogram amplitude was only minimally reduced by ablation: 0.6±2.3 mV (P=0.03). In 4 hearts after IRE delivery, ventricular fibrillation could not be reinduced. At baseline, the lower limit of vulnerability to ventricular fibrillation was 1.8±0.4 J, and the upper limit of vulnerability was 19.5±3.0 J. The window of vulnerability was 17.8±2.9 J. Delivery of electroporation energy significantly reduced the window of vulnerability to 5.7±2.9 J (P=0.0003), with a postablation lower limit of vulnerability=7.3±2.63 J, and the upper limit of vulnerability=18.8±5.2 J. Conclusions-Our study highlights that Purkinje tissue can be ablated with IRE without any evidence of underlying myocardial damage.
AB - Background-The Purkinje network appears to play a pivotal role in the triggering as well as maintenance of ventricular fibrillation. Irreversible electroporation (IRE) using direct current has shown promise as a nonthermal ablation modality in the heart, but its ability to target and ablate the Purkinje tissue is undefined. Our aim was to investigate the potential for selective ablation of Purkinje/fascicular fibers using IRE. Methods and Results-In an ex vivo Langendorff model of canine heart (n=8), direct current was delivered in a unipolar manner at various dosages from 750 to 2500 V, in 10 pulses with a 90-µs duration at a frequency of 1 Hz. The window of ventricular fibrillation vulnerability was assessed before and after delivery of electroporation energy using a shock on T-wave method. IRE consistently eradicated all Purkinje potentials at voltages between 750 and 2500 V (minimum field strength of 250-833 V/cm). The ventricular electrogram amplitude was only minimally reduced by ablation: 0.6±2.3 mV (P=0.03). In 4 hearts after IRE delivery, ventricular fibrillation could not be reinduced. At baseline, the lower limit of vulnerability to ventricular fibrillation was 1.8±0.4 J, and the upper limit of vulnerability was 19.5±3.0 J. The window of vulnerability was 17.8±2.9 J. Delivery of electroporation energy significantly reduced the window of vulnerability to 5.7±2.9 J (P=0.0003), with a postablation lower limit of vulnerability=7.3±2.63 J, and the upper limit of vulnerability=18.8±5.2 J. Conclusions-Our study highlights that Purkinje tissue can be ablated with IRE without any evidence of underlying myocardial damage.
KW - Ablation
KW - Direct current ablation
KW - Irreversible electroporation
KW - Purkinje fibers
KW - Ventricular fibrillation
KW - Window of vulnerability
UR - http://www.scopus.com/inward/record.url?scp=85051427633&partnerID=8YFLogxK
U2 - 10.1161/JAHA.118.009070
DO - 10.1161/JAHA.118.009070
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 30371233
AN - SCOPUS:85051427633
SN - 2047-9980
VL - 7
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 15
M1 - e009070
ER -